No new items were published in the sources we monitor on this date. The open consultations and hearings below remain current.
Federal Official Gazette
No updates.
ANS news
No updates.
Open public consultations
- CP 175. Subject: criticisms and suggestions regarding the preliminary recommendations against the incorporation of the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Deadline: Aug 12, 2026 to Aug 31, 2026
Scheduled public hearings
- AP 68. Subject: preliminary recommendation against the incorporation of the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Date: August 20, 2026, from 9:00 a.m. to 1:00 p.m., virtually, via the Microsoft Teams platform.
Open public calls for input
There is no open public call for input.
Open public calls
There are no open public calls
Other news
– No updates.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.